Altimmune Ownership | Who Owns Altimmune?


OverviewForecastRevenueFinancialsChartTranscripts

Altimmune Ownership Summary


Altimmune is owned by 121.06% institutional investors, 0.42% insiders. Blackrock funding, inc. /de is the largest institutional shareholder, holding 16.38% of ALT shares. Vanguard MStar Total Stk Mkt Idx Invest is the top mutual fund, with 5.18% of its assets in Altimmune shares.

ALT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAltimmune121.06%0.42%-21.48%
SectorHealthcare Stocks 50.51%12.37%37.12%
IndustryBiotech Stocks 48.95%12.07%38.98%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de20.39M16.38%$61.97M
Deep track capital, lp19.25M15.47%$58.52M
Vanguard group9.49M10.61%$34.26M
State street12.10M9.72%$36.78M
Tcg crossover management10.00M8.03%$30.40M
Vanguard capital management8.18M6.57%$24.86M
Marshall wace, llp6.84M5.50%$20.80M
Viking global investors lp6.70M5.38%$20.37M
Ra capital management6.50M5.22%$19.76M
Geode capital management5.01M4.03%$15.24M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Great point partners1.74M1.00%$5.29M
Deep track capital, lp19.25M0.85%$58.52M
Tcg crossover management10.00M0.73%$30.40M
Knoll capital management160.00K0.27%$486.40K
Beirne wealth consulting services421.86K0.26%$1.28M
Birchview capital, lp152.68K0.22%$464.15K
Cormorant asset management, lp1.25M0.19%$3.80M
Ra capital management6.50M0.17%$19.76M
Brown wealth management236.14K0.16%$717.85K
Nantahala capital management1.50M0.15%$4.56M

Top Buyers

HolderShares% AssetsChange
Deep track capital, lp19.25M0.85%19.25M
Tcg crossover management10.00M0.73%10.00M
Blackrock funding, inc. /de20.39M0.00%7.59M
Viking global investors lp6.70M0.06%6.70M
Ra capital management6.50M0.17%6.50M

Top Sellers

HolderShares% AssetsChange
Alyeska investment group---2.64M
Jane street group---1.78M
Bellevue group---1.06M
Capital fund management---726.83K
Schroder investment management group---667.84K

New Positions

HolderShares% AssetsChangeValue
Deep track capital, lp19.25M0.85%19.25M$58.52M
Tcg crossover management10.00M0.73%10.00M$30.40M
Viking global investors lp6.70M0.06%6.70M$20.37M
Ra capital management6.50M0.17%6.50M$19.76M
Woodline partners lp3.40M0.03%3.40M$10.34M

Sold Out

HolderChange
Cornerstone planning group-1.00
Larson financial group-5.00
Capital performance advisors llp-11.00
Twin peaks wealth advisors-13.00
Tradewinds capital management-20.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202621919.67%150,674,020117.20%1211.95%14628.07%33-2.94%
Mar 31, 2026176-12.44%68,583,09625.05%772.07%107-10.08%3512.90%
Dec 31, 202550-72.38%11,431,385-72.45%120.49%32-63.22%4-91.67%
Sep 30, 202562-69.46%8,979,026-74.79%110.58%26-77.39%19-50.00%
Jun 30, 20252077.81%37,429,392-1.85%451.80%11540.24%39-29.09%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard MStar Total Stk Mkt Idx Invest5.75M5.18%-
State Street® SPDR® S&P® Biotech ETF7.97M4.10%18.31K
Vanguard US Total Market Shares ETF2.58M3.36%-
Vanguard Morn Total Stk Mkt Idx Investor5.75M2.96%-434.30K
Vanguard Total Stock Mkt Idx Inv5.75M2.96%-434.30K
iShares Russell 2000 ETF5.05M2.60%-89.66K
Vanguard Institutional Extnd Mkt Idx Tr2.24M2.02%5.04K
Nuveen Quant Small Cap Equity R61.85M1.67%-36.65K
SPDR® S&P Biotech ETF1.24M1.41%2.77K
Vanguard Strategic Equity Inv2.67M1.37%835.79K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 13, 2026Durso Jerome Benedict President and CEOBuy$44.25K
Apr 06, 2026GILL JOHN-Buy$31.35K
Apr 01, 2026WEAVER GREGORY L Chief Financial OfficerBuy$31.50K
Apr 01, 2026Durso Jerome Benedict President and CEOBuy$47.10K
Mar 06, 2026WEAVER GREGORY L Chief Financial OfficerBuy$17.70K

Insider Transactions Trends


DateBuySell
2026 Q31-
2026 Q23-
2026 Q14-
2025 Q43-
2025 Q3--

ALT Ownership FAQ


Who Owns Altimmune?

Altimmune shareholders are primarily institutional investors at 121.06%, followed by 0.42% insiders and -21.48% retail investors. The average institutional ownership in Altimmune's industry, Biotech Stocks , is 48.95%, which Altimmune exceeds.

Who owns the most shares of Altimmune?

Altimmune’s largest shareholders are Blackrock funding, inc. /de (20.39M shares, 16.38%), Deep track capital, lp (19.25M shares, 15.47%), and Vanguard group (9.49M shares, 10.61%). Together, they hold 42.46% of Altimmune’s total shares outstanding.

Does Blackrock own Altimmune?

BlackRock is not among the top 10 institutional shareholders of Altimmune.

Who is Altimmune’s biggest shareholder by percentage of total assets invested?

Great point partners is Altimmune’s biggest shareholder by percentage of total assets invested, with 1.00% of its assets in 1.74M Altimmune shares, valued at 5.29M$.

Who is the top mutual fund holder of Altimmune shares?

Vanguard MStar Total Stk Mkt Idx Invest is the top mutual fund holder of Altimmune shares, with 5.18% of its total shares outstanding invested in 5.75M Altimmune shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools